• This is the beta version of CII Market Place website. Give feedback to help us improve it.

Active Pharmaceutical Ingredients, Advance Intermediates, Allergy Therapy Products, Contract Manufacturing of Sterile Injectables, Crop Science Chemic

By JUBILANT PHARMOVA LTD
  • HSN: (28) INORGANIC CHEMICALS, ORGANIC OR INORGANIC COMPOUNDS OF PRECIOUS METALS, OF RARE-EARTH METALS, OF RADIOACTIVE (29) ELEMENTS OR OF ISOTOPES (30) PHARMACEUTICAL PRODUCTS
Acetyles:

Acetic Anhydride, Ethyl Acetate, Mono Chloro Acetic Acid, SMCA

 

Advance Intermediates:

Pyridine, Beta Picoline, Piperidine, 2 Chloro Pyridine, 2,4,6, Collidine, 4-Dimethyl Amino

 

Fine Ingredients:

Pyridine, 2-Amino Pyridine, 2,6 Lutidine, 2 Amino 4 Methyl Pyridine

 

APIs

Alendronate, Azithromycin Dihydrate, Citalopram, Hydrobromide, Donepezil, Irbesartan, Lamotrigine, Olanzapine, Pinaverium Bromide, Quetiapine Fumarate, Risedronate Sodium, Risperidone, Tramadol, Valsartan

 

Dosage Forms:

Atorvastatin Tablests, Azithromycin Tablets, Donepezil HCl1 Tablets, Entofloxacin Tablets, Irbesartan Tablets, Loasartan Potassium Tablets, Oxcarbazepine Tablets, Pantoprazole Tablets, Sivastatin Tablets, Valacyclovir HCl Tablets
Show More Show Less
Product Description
Acetyles:

Acetic Anhydride, Ethyl Acetate, Mono Chloro Acetic Acid, SMCA

 

Advance Intermediates:

Pyridine, Beta Picoline, Piperidine, 2 Chloro Pyridine, 2,4,6, Collidine, 4-Dimethyl Amino

 

Fine Ingredients:

Pyridine, 2-Amino Pyridine, 2,6 Lutidine, 2 Amino 4 Methyl Pyridine

 

APIs

Alendronate, Azithromycin Dihydrate, Citalopram, Hydrobromide, Donepezil, Irbesartan, Lamotrigine, Olanzapine, Pinaverium Bromide, Quetiapine Fumarate, Risedronate Sodium, Risperidone, Tramadol, Valsartan

 

Dosage Forms:

Atorvastatin Tablests, Azithromycin Tablets, Donepezil HCl1 Tablets, Entofloxacin Tablets, Irbesartan Tablets, Loasartan Potassium Tablets, Oxcarbazepine Tablets, Pantoprazole Tablets, Sivastatin Tablets, Valacyclovir HCl Tablets
Web Link

About the Company

Jubilant Life Sciences Limited is Jubilant Bhartia Group’s flagship company in the pharmaceutical & life sciences segment. Jubilant Bhartia Group, with around 35,000 employees, has a strong presence in diverse sectors like Pharmaceuticals and Life Sciences, Oil and Gas (exploration and production), Agri products, Performance Polymers, Retail, Food and Consulting in Aerospace & Oilfield Services.

Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients. It also provides services in Contract Manufacturing of Sterile Injectables and Drug Discovery . The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services across the value chain.

Our success is an outcome of strategic focus on the pharmaceuticals and life sciences industry, moving up the pharmaceutical value chain for products and services across geographies, constantly investing in various growth platforms and promoting a culture of innovation.

We are engaged in continuous improvement of products and processes to enhance the quality of production and cost competitiveness in order to build value for our customers. Jubilant Life Sciences serves its customers globally with sales in over 100 countries and ground presence in India, North America, Europe and China. We are well recognised as a ‘Partner of Choice’ by leading life sciences companies worldwide. Jubilant has relationship with 19 of Top 20 pharmaceutical and 6 amongst top 10 agrochemical companies across the globe.

Over the years, we have extended our footprint beyond India in the USA, Canada, Europe, and other countries across the globe. This resulted in a network of 7 world class manufacturing facilities in India and 3 in North America and a team of around 6200 multicultural people across the globe with ~ 1500 in North America and ~1000 in R&D.

Jubilant Life Sciences is committed to leverage innovation and scale of operations at every step of the pharmaceutical value chain to deliver value to stakeholders.